Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals
β Scribed by David R. Brigstock
- Book ID
- 107594211
- Publisher
- Springer Netherlands
- Year
- 2009
- Tongue
- English
- Weight
- 195 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1873-9601
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Fibrotic disorders are typified by excessive connective tissue and extracellular matrix (ECM) deposition that precludes normal healing processes of different tissues. Connective tissue growth factor (CTGF) seems to be involved in the fibrotic response. Several muscular dystrophies are c
## Abstract ## Objective Characteristics of osteoarthritis (OA) include cartilage damage, fibrosis, and osteophyte formation. Connective tissue growth factor (CTGF; also known as CCN2), is found in high levels in OA chondrocytes and is frequently involved in fibrosis, bone formation, and cartilage
## Abstract Connective tissue growth factor (CTGF/CCN2) is a cysteineβrich, extracellular matrix (ECM) protein that acts as an anabolic growth factor to regulate osteoblast differentiation and function. Recent studies have identified CTGF as a downstream effector of transforming growth factorβΞ²1 (T
Intraarticular injection of hyaluronan (hyaluronic acid; HA) is the common way to treat osteoarthritis (OA) of knees. This treatment cannot only maintain the viscoelastic properties of knee but also release the OA pain. However, the exact molecular mechanism is unknown. In this study, after human sy